By Dr. Trinh/ November, 2017 In neuroscience research, a new direction in Alzheimer’s clinical trials is to detect the disease early enough to possibly prevent it from progressing. Now, more and more research companies, including Irvine Clinical Research (ICR), are shifting their focus to trying to find and identify Alzheimer’s while symptoms are still mild